Background: Type 2 Diabetes Mellitus (T2DM) is a multifactorial disease that is influenced by genetic, metabolic, and environmental factors. Genetic predisposition, obesity, low physical activity, and unhealthy diet are key risk factors for T2DM. Result: Type 2 diabetes is treated with various natural medicines, the most significant of which is berberine (BBR). Berberine, an isoquinoline alkaloid found in various medicinal plants, exhibits a wide range of pharmacological activities and (BBR) has the potential to treat various diseases, such as diabetes, cancer, and metabolic and cardiovascular diseases. Conclusion: It has been found to be effective in AMPK activation, regulation of blood glucose and lipids, stimulation of insulin secretion from pancreatic beta cells, inhibition of cancer cells, and reduction of fat formation.
Global Health Organization. https://www.who.int/ar/news-room/fact-sheets/detail/diabetes
Purwaningsih, I., Maksum, I.P., Sumiarsa, D. and Sriwidodo, S. (2023) A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant. Molecules , 28, Article 1294. https://doi.org/10.3390/molecules28031294
Chang, W., Chen, L. and Hatch, G.M. (2015) Berberine as a Therapy for Type 2 Diabetes and Its Complications: From Mechanism of Action to Clinical Studies. Biochemistry and Cell Biology , 93, 479-486. https://doi.org/10.1139/bcb-2014-0107
Leslie, R.D., Palmer, J., Schloot, N.C. and Lernmark, A. (2015) Diabetes at the Crossroads: Relevance of Disease Classification to Pathophysiology and Treatment. Diabetologia , 59, 13-20. https://doi.org/10.1007/s00125-015-3789-z
Paschou, S.A., Papadopoulou-Marketou, N., Chrousos, G.P. and Kanaka-Gantenbein, C. (2018) On Type 1 Diabetes Mellitus Pathogenesis. Endocrine Connections , 7, R38-R46. https://doi.org/10.1530/ec-17-0347
Schmidt, A.M. (2018) Highlighting Diabetes Mellitus: The Epidemic Continues. Arteriosclerosis , Thrombosis , and Vascular Biology , 38, e1-e8. https://doi.org/10.1161/atvbaha.117.310221
Guo, J., Chen, H., Zhang, X., Lou, W., Zhang, P., Qiu, Y., et al . (2021) The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxidative Medicine and Cellular Longevity , 2021, Article ID: 2074610. https://doi.org/10.1155/2021/2074610
Shrivastava, S., Sharma, A., Saxena, N., Bhamra, R. and Kumar, S. (2023) Addressing the Preventive and Therapeutic Perspective of Berberine against Diabetes. Heliyon , 9, e21233. https://doi.org/10.1016/j.heliyon.2023.e21233
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., et al . (2020) Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences , 21, Article 6275. https://doi.org/10.3390/ijms21176275
Ibrahim, N.A.B. (2023) An Introduction to Diabetes. Frontiers in Health Informatics , 12, Article 129. https://doi.org/10.30699/fhi.v12i0.405
Panigrahi, A. and Mohanty, S. (2023) Efficacy and Safety of HIMABERB® Berberine on Glycemic Control in Patients with Prediabetes: Double-Blind, Placebo-Controlled, and Randomized Pilot Trial. BMC Endocrine Disorders , 23, Article No. 190. https://doi.org/10.1186/s12902-023-01442-y
Grant, R.W. and Dixit, V.D. (2013) Mechanisms of Disease: Inflammasome Activation and the Development of Type 2 Diabetes. Frontiers in Immunology , 4, Article 50. https://doi.org/10.3389/fimmu.2013.00050
Guamán Ortiz, L., Lombardi, P., Tillhon, M. and Scovassi, A. (2014) Berberine, an Epiphany against Cancer. Molecules , 19, 12349-12367. https://doi.org/10.3390/molecules190812349
Singh, A., Duggal, S., Kaur, N. and Singh, J. (2010) Berberine: Alkaloid with Wide Spectrum of Pharmacological Activities. https://www.scienceopen.com/document?vid=cd6accdf-33ed-4057-b738-ba21e744cef1
Wang, L., Liu, D., Wei, G. and Ge, H. (2021) Berberine and Metformin in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis of Randomized Clinical Trials. Health , 13, 1314-1329. https://doi.org/10.4236/health.2021.1311096
Ali, F., Alom, S. and Zaman, M.K. (2021) Berberine: A Comprehensive Review on Its Isolation, Biosynthesis, Chemistry and Pharmacology. Asian Journal of Chemistry , 33, 2548-2560. https://doi.org/10.14233/ajchem.2021.23365
Gao, Y., Wang, F., Song, Y. and Liu, H. (2020) The Status of and Trends in the Pharmacology of Berberine: A Bibliometric Review [1985-2018]. Chinese Medicine , 15, Article No. 7. https://doi.org/10.1186/s13020-020-0288-z
Ndidi Iheme, K., Ayiwue, Pierre, Hailemeskel, B., Smith, S.A. and Kulkarni, A. (2023) Review of Berberine Use for the Treatment of Type 2 Diabetes Mellitus & Students’ Survey. International Journal of Science and Research Archive , 9, 034-040. https://doi.org/10.30574/ijsra.2023.9.1.0342
Yin, J., Ye, J. and Jia, W. (2012) Effects and Mechanisms of Berberine in Diabetes Treatment. Acta Pharmaceutica Sinica B , 2, 327-334. https://doi.org/10.1016/j.apsb.2012.06.003
Utami, A.R., Maksum, I.P. and Deawati, Y. (2023) Berberine and Its Study as an Antidiabetic Compound. Biology , 12, Article 973. https://doi.org/10.3390/biology12070973
Yang, X., Yang, C. and Lu, W. (2023) Berberine Suppresses Gestational Diabetes in Streptozotocin-Induced Diabetes Mellitus Rats by Suppression of Inflammatory Mediators. Indian Journal of Pharmaceutical Education and Research , 57, 423-431. https://doi.org/10.5530/ijper.57.2.53
Feng, X., Sureda, A., Jafari, S., Memariani, Z., Tewari, D., Annunziata, G., et al . (2019) Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics , 9, 1923-1951. https://doi.org/10.7150/thno.30787
Yin, J., Xing, H. and Ye, J. (2008) Efficacy of Berberine in Patients with Type 2 Diabetes. Metabolism , 57, 712-717. https://doi.org/10.1016/j.metabol.2008.01.013
Xie, W., Su, F., Wang, G., Peng, Z., Xu, Y., Zhang, Y., et al . (2022) Glucose-lowering Effect of Berberine on Type 2 Diabetes: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology , 13, Article 1015045. https://doi.org/10.3389/fphar.2022.1015045